Search research articles
Contact Us
Filters
Showing results (211-220 of 299) with videos related to
Page
of 30
Sort By:
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
September 15, 2022
SupportiNg operAtive Photographic documentation in ileocolonic CROHN's disease surgery: The SNAPCROHN study
Valerio Celentano, Michel Adamina, Antonino Spinelli, et al.
Journal of Crohn'S & Colitis
|
January 13, 2022
ECCO Position on Harmonisation of Crohn's Disease Mucosal Histopathology
F Magro, J Sabino, F Rosini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2022
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)
D Basile, C Broudin, J F Emile, et al.
Journal of Crohn'S & Colitis
|
January 11, 2021
ECCO Topical Review Optimising Reporting in Surgery, Endoscopy, and Histopathology
Michel Adamina, Roger Feakins, Marietta Iacucci, et al.
Journal of Crohn'S & Colitis
|
August 22, 2023
Definitions of Histological Abnormalities in Inflammatory Bowel Disease: an ECCO Position Paper
Roger Feakins, Paula Borralho Nunes, Ann Driessen, et al.
Endocrine Pathology
|
October 29, 2025
Performance of Immunohistochemistry to Detect Rb/p53 Alterations in High-Grade Neuroendocrine Neoplasms: Staining Patterns and Comparison with Genetic Testing
Ruiqian Chen, Matthieu Tihy, Ludovic Lacroix, et al.
Journal of Crohn'S & Colitis
|
November 2, 2024
Impact of Histological Remission for Predicting Clinical Relapse in Crohn's Disease: A Post Hoc Analysis of the Prospective STORI Cohort
Catherine Reenaers, Diana Enea, Marie Nachury, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2020
Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR)
Jean-François Delattre, Romain Cohen, Julie Henriques, et al.
Journal for Immunotherapy of Cancer
|
November 5, 2020
RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study
Romain Cohen, Jaafar Bennouna, Aurélia Meurisse, et al.
Oncogene
|
September 15, 2015
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
A-L Joly, A Deepti, A Seignez, et al.
Page
of 30
Search research articles
Search
Showing results (211-220 of 299) with videos related to
Sort By:
Page
of 30
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
September 15, 2022
SupportiNg operAtive Photographic documentation in ileocolonic CROHN's disease surgery: The SNAPCROHN study
Valerio Celentano, Michel Adamina, Antonino Spinelli, et al.
Journal of Crohn'S & Colitis
|
January 13, 2022
ECCO Position on Harmonisation of Crohn's Disease Mucosal Histopathology
F Magro, J Sabino, F Rosini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2022
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)
D Basile, C Broudin, J F Emile, et al.
Journal of Crohn'S & Colitis
|
January 11, 2021
ECCO Topical Review Optimising Reporting in Surgery, Endoscopy, and Histopathology
Michel Adamina, Roger Feakins, Marietta Iacucci, et al.
Journal of Crohn'S & Colitis
|
August 22, 2023
Definitions of Histological Abnormalities in Inflammatory Bowel Disease: an ECCO Position Paper
Roger Feakins, Paula Borralho Nunes, Ann Driessen, et al.
Endocrine Pathology
|
October 29, 2025
Performance of Immunohistochemistry to Detect Rb/p53 Alterations in High-Grade Neuroendocrine Neoplasms: Staining Patterns and Comparison with Genetic Testing
Ruiqian Chen, Matthieu Tihy, Ludovic Lacroix, et al.
Journal of Crohn'S & Colitis
|
November 2, 2024
Impact of Histological Remission for Predicting Clinical Relapse in Crohn's Disease: A Post Hoc Analysis of the Prospective STORI Cohort
Catherine Reenaers, Diana Enea, Marie Nachury, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2020
Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR)
Jean-François Delattre, Romain Cohen, Julie Henriques, et al.
Journal for Immunotherapy of Cancer
|
November 5, 2020
RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study
Romain Cohen, Jaafar Bennouna, Aurélia Meurisse, et al.
Oncogene
|
September 15, 2015
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development
A-L Joly, A Deepti, A Seignez, et al.
Page
of 30